Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review

IMPORTANCE: For nearly a century, no generic form of insulin has been available in the United States. However, the first biosimilar insulin, Basaglar, was approved by the U.S. Food and Drug Administration in 2015, and subsequently Admelog and Lusduna in 2017. OBJECTIVE: To summarize the scientific e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Tieu, Carolyn, Lucas, Eleanor J., DePaola, Mindi, Rosman, Lori, Alexander, G. Caleb
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905882/
https://ncbi.nlm.nih.gov/pubmed/29668697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0195012
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky